Ray Ward Fuller

Ray Ward Fuller's AcademicInfluence.com Rankings

Ray Ward Fuller

Biology

#5397

World Rank

#7867

Historical Rank

Endocrinology

#46

World Rank

#54

Historical Rank

Neuroscience

#602

World Rank

#628

Historical Rank

biology Degrees

Download Badge

Biology

Ray Ward Fuller's Degrees

PhD Neuroscience Stanford University
Masters Biology Stanford University
Bachelors Biology Stanford University

Similar Degrees You Can Earn

Why Is Ray Ward Fuller Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Ray Ward Fuller's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Vasopressin/Serotonin Interactions in the Anterior Hypothalamus Control Aggressive Behavior in Golden Hamsters (1997) (490)
Uptake inhibitors increase extracellular serotonin concentration measured by brain microdialysis. (1994) (259)
Effect of fluoxetine on serotonin and dopamine concentration in microdialysis fluid from rat striatum. (1992) (222)
Dopamine deficiency in the weaver mutant mouse (1982) (209)
Effect of an uptake inhibitor on serotonin metabolism in rat brain: studies with 3-(p-trifluoromethylphenoxy)-N-methyl-3-phenylpropylamine (Lilly 110140). (1974) (203)
Evidence for 5-HT2 receptors mediating contraction in vascular smooth muscle. (1981) (187)
Fluoxetine, a selective inhibitor of serotonin uptake (1991) (177)
Serotonin Uptake and Serotonin Uptake Inhibition (1990) (176)
The pharmacologic profile of fluoxetine. (1985) (173)
Chronic dietary pergolide preserves nigrostriatal neuronal integrity in aged-Fischer-344 rats (1992) (151)
Mechanisms of effects of d-Fenfluramine on brain serotonin metabolism in rats: Uptake inhibition versus release (1988) (147)
Absolute configurations and pharmacological activities of the optical isomers of fluoxetine, a selective serotonin-uptake inhibitor. (1988) (143)
Inhibition of serotonin reuptake. (1977) (138)
NMDA receptor antagonists suppress behaviors but not norepinephrine turnover or locus coeruleus unit activity induced by opiate withdrawal. (1991) (138)
Disposition and pharmacological effects of m-Chlorophenylpiperazine in rats (1981) (132)
LOWERING OF BRAIN SEROTONIN LEVEL BY CHLORAMPHETAMINES. (1965) (125)
Resolution and absolute configuration of an ergoline-related dopamine agonist, trans-4,4a,5,6,7,8,8a,9-Octahydro-5-propyl-1H(or 2H)-pyrazolo[3,4-g]quinoline. (1983) (122)
Kinetics of serotonin accumulation into synaptosomes of rat brain--effects of amphetamine and chloroamphetamines. (1973) (118)
Long-lasting depletion of striatal dopamine by a single injection of amphetamine in iprindole-treated rats. (1980) (114)
Effect of 3-(p-trifluoromethylphenoxy). N. N. methyl-3-phenylpropylamine on the depletion of brain serotonin by 4-chloroamphetamine. (1975) (114)
LY53857, a selective and potent serotonergic (5-HT2) receptor antagonist, does not lower blood pressure in the spontaneously hypertensive rat. (1983) (114)
Reversible and irreversible phases of serotonin depletion by 4-chloroamphetamine. (1975) (113)
Synthesis of 3-deazaneplanocin A, a powerful inhibitor of S-adenosylhomocysteine hydrolase with potent and selective in vitro and in vivo antiviral activities. (1989) (111)
Effects of (8beta)-8-[methylthio)methyl]-6-propylergoline on dopaminergic function and brain dopamine turnover in rats. (1979) (102)
Serotonin receptor subtypes involved in the elevation of serum corticosterone concentration in rats by direct- and indirect-acting serotonin agonists. (1990) (100)
Serotonin receptors involved in regulation of pituitary-adrenocortical function in rats (1995) (99)
Neurochemical evidence for antagonism by olanzapine of dopamine, serotonin, α1-adrenergic and muscarinic receptors in vivo in rats (1996) (99)
Importance of duration of drug action in the antagonism of p-chloroamphetamine depletion of brain serotonin-comparison of fluoxetine and chlorimipramine. (1978) (95)
Supersensitization of the oral response to SKF 38393 in neonatal 6-OHDA-lesioned rats is mediated through a serotonin system. (1992) (94)
The Influence of Fluoxetine on Aggressive Behavior (1996) (94)
Brain anoxia releases striatal dopamine in rats. (1986) (93)
Effect of serotonin-releasing drugs on serum corticosterone concentration in rats. (1980) (92)
The involvement of serotonin in regulation of pituitary-adrenocortical function. (1992) (91)
Isolation and structure/activity features of halomon-related antitumor monoterpenes from the red alga Portieria hornemannii. (1994) (85)
Effects of buspirone and its metabolite, 1-(2-pyrimidinyl)piperazine, on brain monoamines and their metabolites in rats. (1989) (84)
Serotonin receptors and neuroendocrine responses. (1990) (84)
Comparison of norfluoxetine enantiomers as serotonin uptake inhibitors in vivo (1992) (81)
Pharmacologic evidence for a serotonin neural pathway involved in hypothalamus-pituitary-adrenal function in rats. (1976) (78)
Basic advances in serotonin pharmacology. (1992) (77)
Further studies on the long-term depletion of striatal dopamine in iprindole-treated rats by amphetamine (1982) (76)
Proposed animal model of attention deficit hyperactivity disorder (1994) (75)
Lowering of epinephrine concentration in rat brain by 2,3-dichloro-alpha-methyl-benzylamine, an inhibitor of norepinephrine N-methyltransferase. (1977) (74)
Elevation of serum corticosterone concentrations in rats by pergolide and other dopamine agonists. (1981) (73)
Serotonin Reuptake Blockers in Vitro and in Vivo (1987) (72)
Evidence that blood pressure reduction by serotonin antagonists is related to alpha receptor blockade in spontaneously hypertensive rats. (1983) (71)
Evaluation of nefopam as a monoamine uptake inhibitor in vivo in mice (1993) (70)
The effects of quipazine on serotonin metabolism in rat brain. (1976) (70)
Serotonin uptake inhibitors: uses in clinical therapy and in laboratory research. (1995) (68)
Further evidence that vascular serotonin receptors are of the 5HT2 type. (1983) (66)
Effects of duloxetine, an antidepressant drug candidate, on concentrations of monoamines and their metabolites in rats and mice. (1994) (65)
Inhibition of serotonin uptake by optical isomers of fluoxetine (1985) (65)
Fluoxetine increases long-lasting neostriatal dopamine depletion after administration of d-methamphetamine and d-amphetamine (1983) (65)
Comparison between the neurotoxic and serotonin-depleting effects of various halogenated derivatives of amphetamine in the rat. (1977) (64)
Supersensitization of the oral response to SKF 38393 in neonatal 6-hydroxydopamine-lesioned rats is eliminated by neonatal 5,7-dihydroxytryptamine treatment. (1994) (64)
Extracellular 5‐hydroxytryptamine concentration in rat hypothalamus after administration of fluoxetine plus l‐5‐hydroxytryptophan (1993) (63)
Substituted piperazines as central serotonin agonists: comparative specificity of the postsynaptic actions of quipazine and m-trifluoromethylphenylpiperazine. (1981) (60)
Feeding Schedule Alteration of Daily Rhythm in Tyrosine Alpha-Ketoglutarate Transaminase of Rat Liver (1968) (60)
Fluoxetine, a Highly Selective Serotonin Reuptake Inhibitor: A Review of Preclinical Studies (1988) (59)
Effect of 1-(m-trifluoromethylphenyl)-piperazine on 3H-serotonin binding to membranes from rat brain in vitro and on serotonin turnover in rat brain in vivo. (1978) (58)
Frequent Occurrence of HIV-Inhibitory Sulphated Polysaccharides in Marine Invertebrates (1993) (57)
Kinetic studies and effects in vivo of a new monoamine oxidase inhibitor, N-[2-(o-chlorophenoxy)-ethyl]-cyclopropylamine. (1968) (56)
Structural relationships in the inhibition of [(3)H]serotonin binding to rat brain membranes in vitro by 1-phenyl-piperazines. (1980) (56)
Selective inhibition of monoamine oxidase in rat brain mitochondria. (1970) (56)
Use of specific serotonin uptake inhibitors as antidepressants. (1985) (55)
Antagonism of vascular serotonin receptors by m-chlorophenylpiperazine and m-trifluoromethylphenylpiperazine. (1983) (54)
Inhibition of methyltransferases by some new analogs of S-adenosylhomocysteine. (1978) (52)
Central and peripheral catecholamine depletion by 1-methyl-4-phenyl-tetrahydropyridine (MPTP) in rodents. (1985) (52)
Fluoxetine and its two enantiomers as selective serotonin uptake inhibitors. (1990) (50)
Role of serotonin in therapy of depression and related disorders. (1991) (50)
Comparison of the specificity of 3-(p-trifluoromethylphenoxy)-N-methyl-3-phenylpropylamine and chlorimipramine as amine uptake inhibitors in mice. (1974) (49)
Interactions of trazodone with serotonin neurons and receptors (1984) (47)
Serotonin oxidation by rat brain monoamine oxidase: Inhibition by 4-chloroamphetamine (1966) (46)
Determination of brain concentrations of 8-hydroxy-2-(di-n-propylamino)tetralin by liquid chromatography with electrochemical detection. (1989) (46)
The effects of metergoline and other serotonin receptor antagonists on serum corticosterone in rats. (1979) (46)
Effects of Fenfluramine and Norfenfluramine on Brain Serotonin Metabolism in Rats (1978) (46)
Effects ofp-chloroamphetamine on brain serotonin neurons (1992) (46)
Long-term effects of 4-chloroamphetamine on brain 5-hydroxyindole metabolism in rats. (1974) (45)
Dose-related effects of a neonatal 6-OHDA lesion on SKF 38393- and m-chlorophenylpiperazine-induced oral activity responses of rats. (1993) (45)
Diffuse interstitial renal tuberculosis--an unusual cause of renal failure. (1981) (44)
Altered behavioral response to a D2 agonist, LY141865, in spontaneously hypertensive rats exhibiting biochemical and endocrine responses similar to those in normotensive rats. (1983) (44)
Antihypertensive effects of fluoxetine and L-5-hydroxytryptophan in rats. (1979) (44)
Substrate specificity of phenethanolamine N-methyl transferase. (1965) (43)
Pharmacological activity of the isomers of LY53857, potent and selective 5-HT2 receptor antagonists. (1985) (43)
Apomorphine-induced aggression in rats chronically treated with oral clonidine: modulation by central serotonergic mechanisms. (1982) (42)
Elevation of serum corticosterone in rats by dopamine agonists related in structure to pergolide. (1983) (42)
In vivo cardiovascular responses to isoproterenol, dopamine and tyramine after prolonged infusion of isoproterenol. (1984) (42)
Fluoxetine increases norepinephrine release in rat hypothalamus as measured by tissue levels of MHPG-SO4 and microdialysis in conscious rats (2005) (42)
Comparison of the oxime and the hydroxylamine derivatives of 4-chloroamphetamine as depletors of brain 5-hydroxyindoles. (1974) (42)
Inhibition of phenethanolamine Neethyl transferase by its product, epinephrine. (1967) (41)
Evaluation of nefazodone as a serotonin uptake inhibitor and a serotonin antagonist in vivo. (1994) (41)
Depletion of cardiac norepinephrine in rats and mice by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). (1984) (40)
Properties of 8,9-dichloro-2,3,4,5-tetrahydro-1H-2-benzazepine, an inhibitor of norepinephrine N-methyltransferase. (1981) (40)
The effect of quipazine, a serotonin receptor agonist, on serum corticosterone concentration in rats. (1978) (40)
Fluoxetine: A serotonergic appetite suppressant drug (1989) (39)
Sympathetic noradrenergic innervation of guinea-pig liver: histofluorescence and pharmacological studies. (1981) (39)
Inhibition of types A and B monoamine oxidase by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. (1985) (39)
Comparative effects of pemoline, amfonelic acid and amphetamine on dopamine uptake and release in vitro and on brain 3,4‐dihydroxyphenylacetic acid concentration in spiperone‐treated rats (1978) (39)
Age-dependence of a 6-hydroxydopamine lesion on SKF 38393- and m-chlorophenylpiperazine-induced oral activity responses of rats. (1993) (38)
Blockade of amine depletion by nisoxetine in comparison to other uptake inhibitors. (1975) (38)
Tissue levels of chloroamphetamines in rats and mice. (1967) (36)
Daily Rhythm in Plasma Tyrosine and Phenylalanine (1968) (36)
Preclinical studies on LY228729: a potent and selective serotonin1A agonist. (1993) (35)
Deprenyl antagonizes acute lethality of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice. (1988) (35)
Preclinical pharmacology of fluoxetine, a serotonergic drug for weight loss. (1992) (35)
Novel halogenated analogs of tomoxetine that are potent and selective inhibitors of norepinephrine uptake in brain (1995) (35)
Comparison of 4-chloro-, 4-bromo- and 4-fluoroamphetamine in rats: Drug levels in brain and effects on brain serotonin metabolism (1975) (34)
A micromethod for the assay of phenethanolamine N-methyl transferase. (1966) (34)
Noradrenergic innervation of the cerebellar cortex in normal and in Purkinje cell degeneration mutant mice: Evidence for long term survival following loss of the two major cerebellar cortical neuronal populations (1986) (34)
Pharmacological characterization of LY293284: A 5-HT1A receptor agonist with high potency and selectivity. (1994) (33)
Binding of tryptophan to plasma proteins in several species. (1973) (33)
Elevation of 3, 4‐dihydroxyphenylacetic acid concentrations in rat brain and stimulation of prolactin secretion by fenfluramine: evidence for antagonism at dopamine receptor sites (1976) (33)
Influence of selective, reversible inhibitors of monoamine oxidase on the prolonged depletion of striatal dopamine by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice. (1985) (32)
The selective norepinephrine reuptake inhibitor, LY368975, reduces food consumption in animal models of feeding. (1998) (32)
NEUROCHEMICAL EFFECTS OF SEROTONIN NEUROTOXINS: AN INTRODUCTION (1978) (31)
Fluoxetine Effects on Serotonin Function and Aggressive Behavior (1996) (31)
Inhibition of amino acid transaminases by L-cycloserine. (1973) (30)
Neuroendocrine evidence for antagonism of serotonin and dopamine receptors by olanzapine (LY170053), an antipsychotic drug candidate. (1992) (30)
6-substituted 1,3,4,5-tetrahydrobenz[cd]indol-4-amines: potent serotonin agonists. (1988) (30)
Inhibition of monoamine oxidase by N-(phenoxyethyl)cyclopropylamines. Correlation of inhibition with Hammett constants and partition coefficients. (1968) (30)
STRUCTURE‐ACTIVITY RELATIONSHIPS AMONG THE HALOGENATED AMPHETAMINES (1978) (30)
Potentiation of the L-5-hydroxytryptophan-induced elevation of plasma corticosterone levels in rats by a specific inhibitor of serotonin uptake. (1975) (29)
Ontogenetic SKF 38393 treatments sensitize dopamine D1 receptors in neonatal 6-OHDA-lesioned rats. (1993) (29)
Central dopamine receptors mediating pergolide-induced elevation of serum corticosterone in rats Characterization by the use of antagonists (1984) (29)
Purkinje cell loss and the noradrenergic system in the cerebellum of pcd mutant mice (1981) (29)
Protection against amphetamine-induced neurotoxicity toward striatal dopamine neurons in rodents by LY274614, an excitatory amino acid antagonist (1992) (29)
Tissue distribution, metabolism and effects of bufotenine administered to rats (1995) (28)
Depletion of norepinephrine in mouse heart by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mimicked by 1-methyl-4-phenylpyridinium (MPP+) and not blocked by deprenyl. (1986) (28)
Persistent spontaneous oral dyskinesias in haloperidol-withdrawn rats neonatally lesioned with 6-hydroxydopamine: absence of an association with the Bmax for [3H]raclopride binding to neostriatal homogenates. (1997) (27)
Inhibition of phenethanolamine N-methyl transferase by ring-substituted alpha-methylphenethylamines (amphetamines). (1971) (27)
Dissociation of the effects of p-chlorophenylalanine on self-stimulation and on brain serotonin. (1970) (27)
Inhibition of phenylethanolamine N-methyltransferase by benzylamines. 1. Structure-activity relationships. (1973) (27)
The response of "obese" (ob-ob) and "diabetic" (db-db) mice to treatments that influence body temperature. (1974) (27)
Central serotonin agonist actions of LY 165163, 1-(m-trifluoromethylphenyl)-4-(p-aminophenylethyl) piperazine, in rats. (1986) (26)
Blockade of a 5-hydroxytryptophan-induced animal model of depression with a potent and selective 5-HT2 receptor antagonist (LY53857) (1985) (26)
Comparison of desmethylsertraline with sertraline as a monoamine uptake inhibitor in vivo (1995) (25)
Inhibition of phenylethanolamine N-methyltransferase by benzylamines. 2. In vitro and in vivo studies with 2,3-dichloro- -methylbenzylamine. (1973) (25)
Cytidine and deoxycytidylate deaminase inhibition by uridine analogs. (1980) (25)
Substrate specificity of phenethanolamine N-methyltransferase from rabbit adrenal. (1970) (25)
d-amphetamine levels in brain and other tissues of isolated and aggregated mice (1967) (24)
Serotonergic mechanisms in feeding. (1987) (24)
N-substituted cyclopropylamines as inhibitors of MAO-A and -B forms. (1978) (24)
Accumulation of amphetamine and p‐chloroamphetamine into synaptosomes of rat brain (1972) (24)
A POSSIBLE ROLE OF SEROTONIN IN HYPOTHALAMIC SELF-STIMULATION IN DOGS. (1964) (24)
Studies on the effects on N,N'-dimethylformamide on ethanol disposition and on monoamine oxidase activity in rats. (1977) (24)
Species differences in epinephrine concentration and norepinephrine N-methyltransferase activity in hypothalamus and brain stem. (1983) (23)
Striatal dopamine turnover and MIF-I (1979) (23)
Preclinical studies on LY237733, a potent and selective serotonergic antagonist. (1992) (23)
Effects of antidepressants on uptake and receptor systems in the brain (1985) (23)
Formation of α-methylnorepinephrine as a metabolite of metaraminol in guinea pigs (1981) (23)
Daily Variation in Liver Tryptophan, Tryptophan Pyrrolase, and Tyrosine Transaminase in Rats Fed ad Libitum or Single Daily Meals (1970) (23)
Behavioral and biochemical effects of p-chlorophenylalanine, 3-chlorotyrosine and 3-chlorotyramine. A proposed mechanism for inhibition of self-stimulation. (1972) (23)
Regulation of phenylethanolamine N-methyl transferase. (1974) (23)
Mechanisms and Functions of Serotonin Neuronal Systems (1996) (22)
Tissue concentrations of MPTP and MPP+ in relation to catecholamine depletion after the oral or subcutaneous administration of MPTP to mice. (1989) (22)
Elevation by fenfluramine of 3,4-dihydroxyphenylacetic acid in brain and of corticosterone and prolactin in serum of fenfluramine-pretreated rats. (1981) (22)
MD 240928 and harmaline: opposite selectivity in antagonism of the inactivation of types A and B monoamine oxidase by pargyline in mice. (1986) (22)
Dopamine accumulation after dopamine beta-hydroxylase inhibition in rat heart as an index of norepinephrine turnover. (1982) (21)
Biological disposition of rigid analogs of amphetamine. (1977) (21)
Serotonin concentration and turnover in cerebelum and other brain regions of pcd mutant mice (1988) (21)
The Pharmacology and Therapeutic Potential of Serotonin Receptor Agonists and Antagonists (1989) (21)
Fluoxetine enantiomers as antagonists of p-chloroamphetamine effects in rats (1986) (21)
Comparison of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridinium (MPP+) effects on mouse heart norepinephrine. (1988) (20)
Elevation of serum corticosterone in rats by bremazocine, a κ‐opioid agonist (1984) (20)
Effects of intraventricuear p-chloroamphetamine and its analogues on cerebral 5-HT (1975) (20)
Further structure-activity studies on the lowering of brain 5-hydroxyindoles by 4-chloramphetamine. (1973) (20)
Serum Uric Acid in Young Mongoloids (1963) (20)
Increase of pineal noradrenaline concentration in rats by desipramine but not fluoxetine: implications concerning the specificity of these uptake inhibitors (1977) (20)
Involvement of 5-HT2A receptors in the elevation of rat serum corticosterone concentrations by quipazine and MK-212. (1996) (20)
Differential effects of selected dopaminergic agents on locomotor activity in normotensive and spontaneously hypertensive rats (1985) (20)
α2 andrenoreceptor affinity of some inhibitors of norepinephrine N-methyltransferase (1981) (20)
Drug disposition as a factor in the lowering of brain serotonin by chloroamphetamines in the rat. (1972) (20)
Comparison of the effects of two 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine analogs, 1-methyl-4-(2-thienyl)-1,2,3,6-tetrahydropyridine and 1-methyl-4-(3-thienyl)-1,2,3,6-tetrahydropyridine, on monoamine oxidase in vitro and on dopamine in mouse brain. (1987) (19)
Lowering of blood pressure by direct- and indirect-acting serotonin agonists in spontaneously hypertensive rats. (1981) (19)
N-substituted cyclopropylamines as monoamine oxidase inhibitors. Structure-activity relationships. Dopa potentiation in mice and in vitro inhibition of kynuramine oxidation. (1968) (19)
Selectivity among monoamine oxidase inhibitors and its possible importance for development of antidepressant drugs (1978) (19)
Induction of tyrosine aminotransferase in rat liver by epinephrine and theophylline. (1970) (19)
The effect of fluoxetine on morphine analgesia, respiratory depression, and lethality (1982) (19)
(R)-thionisoxetine, a potent and selective inhibitor of central and peripheral norepinephrine uptake. (1995) (19)
Mechanisms of MPTP (1-methyl-4-phenyl-l, 2, 3, 6-tetrahydropyridine) neurotoxicity to striatal dopamine neurons in mice (1985) (19)
Serum Corticosterone Increases Reflect Enhanced Uptake Inhibitor‐induced Elevation of Extracellular 5−Hydroxytryptamine in Rat Hypothalamus (1996) (19)
Preclinical pharmacology of a new serotonergic receptor antagonist, LY281067. (1988) (19)
Functional Significance of the Sympathetic Nervous System in Production of Hypertension (1969) (19)
Elevation of plasma corticosterone by swim stress and insulin-induced hypoglycemia in control and fluoxetine-pretreated rats. (1977) (19)
Dopamine depletion in rat brain by MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) (1983) (18)
Comparison of MPTP and Amphetamines as Dopaminergic Neurotoxins (1992) (18)
The rise and fall of MTHF as a methyl donor in biogenic amine metabolism. (1976) (18)
Effect of prazosin on norepinephrine concentration and turnover in rat brain and heart. (1978) (18)
p-Iodoamphetamine as a serotonin depletor in rats. (1980) (18)
Inhibition of drug metabolism by fluoxetine. (1976) (18)
Inhibition of monoamine oxidase action on kynuramine by substrate amines and stereoisomeric α-methyl amines (1965) (17)
Isolation and purification of rabbit adrenal norephinephrine N-methyl transferase isozymes. (1978) (17)
Inability of methylphenidate or mazindol to prevent the lowering of 3,4‐dihydroxyphenylacetic acid in rat brain by amphetamine (1979) (17)
Drug concentrations in mouse brain at pharmacologically active doses of fluoxetine enantiomers. (1993) (17)
Enhanced selectivity of pargyline as an inhibitor of type B monoamine oxidase in harmaline-treated rats. (1978) (17)
Isolation of multiple forms of rabbit-adrenal norepinephrine N-methyltransferase. (1974) (16)
Dextromethorphan antagonizes the acute depletion of brain serotonin by p-chloroamphetamine and H75/12 in rats (1992) (16)
Studies of noradrenergic influence on cardiac ornithine decarboxylase in rats. (1978) (16)
Effect of norfenfluramine and two structural analogues on brain 5‐hydroxyindoles and serum prolactin in rats (1982) (16)
Methiothepin elevation of 5-hydroxyindoleacetic acid levels in various anatomic regions of rat brain. (1974) (15)
DIFFERENCES IN THE REGULATION OF TYROSINE AMINOTRANSFERASE IN BRAIN AND LIVER (1970) (15)
Structure-activity correlation for substrates of phenylethanolamine N-methyltransferase (PNMT). (1972) (15)
New inhibitors of dopamine β-hydroxylase (1977) (15)
Persistent depletion of striatal dopamine in mice by 1-methyl-4-(2-thienyl)-1,2,3,6-tetrahydropyridine (MTTP). (1986) (15)
Deprenyl protection against striatal dopamine depletion by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice (1984) (15)
Persistent depletion of striatal dopamine and its metabolites in mice by TMMP, an analogue of MPTP (1987) (15)
The Effect of Aliphatic Fluorine on Amine Drugs (1976) (15)
Effect of , -difluoro substitution on the disposition and pharmacological effects of 4-chloroamphetamine in rats. (1973) (15)
On the In‐vivo Modulation of Neostriatal Dopamine Release by Fluoxetine and 5−Hydroxy‐L‐tryptophan in Conscious Rats (1996) (15)
Increase of hepatic L-phenylalanine: pyruvate aminotransferase by glucagon in rats. Possible role of adenosine cyclic 3',5'-monophosphate as a mediator. (1972) (14)
Substituted 5-amino-4,5,6,7-tetrahydroindazoles as partial ergoline structures with dopaminergic activity. (1989) (14)
Mechanism by which uptake inhibitors antagonizep-chloroamphetamine-induced depletion of brain serotonin (1980) (14)
Tissue concentrations of MPTP and MPP+ after administration of lethal and sublethal doses of MPTP to mice. (1990) (14)
Microdialysis studies with 5-HT reuptake inhibitors. (1993) (14)
Inhibition of monoamine oxidase by N-phenacyl-cyclopropylamine. (1978) (14)
Recent studies with 4-chloramphetamine and some analogues. (1974) (14)
Pharmacological characterization of enantiomers of 8‐thiomethyl‐2‐(di‐n‐propylamino)tetralin, potent and selective 5‐HT1A receptor agonists (1995) (13)
Effect of a stereospecific D2-dopamine agonist on acetylcholine concentration in corpus striatum of rat brain (2005) (13)
Characterization of the neurotoxic potential of m-methoxy-MPTP and the use of its N-ethyl analogue as a means of avoiding exposure to a possible Parkinsonism-causing agent. (1986) (13)
Norepinephrine metabolism in the cerebellum of the purkinje cell degeneration (pcd) mutant mouse (1987) (13)
Effects of L-dopa on epinephrine concentration in rat brain: possible role of inhibition of norepinephrine N-methyltransferase by S-adenosylhomocysteine. (1982) (13)
Different effects of monoamine oxidase inhibition on MPTP depletion of heart and brain catecholamines in mice. (1988) (13)
Oral versus parenteral efficacy of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): differential effects on depletion of heart norepinephrine and of striatal dopamine in mice. (1987) (13)
Decreased accumulation of brain 5‐hydroxytryptophan after decarboxylase inhibition in rats treated with fenfluramine, norfenfluramine or p‐chloroamphetamine (1983) (12)
Metabolism of amphetamine and β,β-difluoroamphetamine in phenobarbital-treated rats (1973) (12)
Substrates and inhibitors of phenyletholamine n-methyl transferase from human adrenal glands (1972) (12)
INHIBITION OF RAT LIVER TRYPTOPHAN HYDROXYLASE IN VITRO. (1965) (12)
Nisoxetine antagonism of norepinephrine depletion in brain and heart after α-methyl-m-tyrosine administration (1979) (12)
Product inhibition studies and the reaction sequence of rabbit adrenal norepinephrine N-methyl transferase isozymes. (1978) (12)
Inhibition of serotonin uptake and the toxic interaction between meperidine and monoamine oxidase inhibitors. (1975) (12)
Lowering of rat brain 3‐methoxy‐4‐hydroxyphenylethylene glycol sulphate (MOPEG sulphate) concentration by 2,6‐dichlorobenzylidene aminoguanidine (1977) (12)
Inhibition by p‐chloroamphetamine of the conversion of 5‐hydroxytryptamine to 5‐hydroxyindoleacetic acid in rat brain (1970) (12)
Disposition and behavioral effects of amphetamine and , -difluoroamphetamine in mice. (1972) (12)
Mechanisms and functions of serotonin neuronal systems: opportunities for neuropeptide interactions. (1996) (11)
RESOLUTION AND ABSOLUTE CONFIGURATION OF AN ERGOLINE-RELATED DOPAMINE AGONIST, TRANS-4,4A,5,6,7,8,8A,9-OCTAHYDRO-5-PROPYL-1H(OR 2H)-PYRAZOLO(3,4-G)QUINOLINE (1983) (11)
Effect of fluoxetine pretreatment on plasma and tissue concentrations of desipramine in rats. (1989) (11)
Possible involvement of dopamine in the long-term serotonin depletion by p-chloroamphetamine and beta,beta-difluoro-p-chloroamphetamine in rats. (1993) (11)
Inability of an inhibitor of amine uptake (Lilly 110140) to block depletion of brain 5‐hydroxytryptamine by l‐dopa (1975) (11)
Activity of Phenethanolamine N-Methyl Transferase in the Adrenal Glands of Foetal and Neonatal Rats (1967) (11)
MK‐801 Protects Against Amphetamine‐Induced Striatal Dopamine Depletion in Iprindole‐Treated Rats, but not Against Brain Serotonin Depletion after p‐Chloroamphetamine Administration (1992) (10)
Influence of route of administration on potency of the selective 5HT-1A agonist, 8-hydroxy-2-(di-n-propylamino)tetralin, in rats. (1987) (10)
Metabolic interactions between nortriptyline and thioridazine in rats. (1974) (10)
Inhibition in vitro of rabbit adrenal norepinephrine N-methyltransferase by 2,3,4,5-tetrahydro-1H-2-benzazepines. (1979) (10)
Tropolone antagonism of the l−dopa‐induced elevation of S‐adenosylhomocysteine: S‐adenosylmethionine ratio but not depletion of adrenaline in rat hypothalamus (1984) (10)
Elevation of 3, 4‐dihydroxyphenylacetic acid concentration by L‐5‐hydroxytryptophan in control and fluoxetine‐pretreated rats (1981) (10)
N-[2-(o-iodophenoxy)ethyl]cyclopropylamine hydrochloride (LY121768), a potent and selective irreversible inhibitor of type A monoamine oxidase. (1983) (10)
L‐Tyrosine enhancement of the elevation of 3,4‐dihydroxyphenylacetic acid concentration in rat brain by spiperone and amfonelic acid (1982) (10)
Methylation of norepinephrine and α-methylnorepinephrine in brain (1982) (10)
Influence of harmaline on the ability of pargyline to alter catecholamine metabolism in rats. (1981) (9)
The interaction of rabbit adrenal norepinephrine N-methyl transferase isozymes with substrates. (1978) (9)
Daily rhythm of liver tyrosine transaminase and of plasma tyrosine and glucose after removal of the pancreas of rats. (1969) (9)
Cardiovascular effects of LY134046, an inhibitor of norepinephrine N-methyltransferase, in spontaneously hypertensive rats. (1983) (9)
Effect of glucagon and p-chlorophenylalanine on hepatic enzymes that metabolize phenylalanine. (1972) (9)
PHARMACOLOGIC MODIFICATION OF ADRENALINE NEURONS IN RAT BRAIN (1980) (9)
Selective inhibition of monoamine oxidase. (1972) (9)
Norepinephrine, monoamine oxidase, and acetylcholinesterase in the rat jugular vein compared with other blood vessels. (1979) (8)
Comparison of the effects of 6-chloro-2-aminotetralin and of Org 6582, a related chloroamphetamine analog, on brain serotonin metabolism in rats (1977) (8)
Pharmacologic modification of serotonergic function: drugs for the study and treatment of psychiatric and other disorders. (1986) (8)
Further studies on the effects of N-cyclopropyl-p-chloroamphetamine in rat brain (1977) (8)
A high dose of MPTP overcomes the protective effect of selegiline against dopaminergic neurotoxicity (1989) (8)
6-Chloro-2-aminotetralin, a rigid Conformational analog of 4-chloroamphetamine: pharmacologic properties of it and related compounds in rats. (1974) (8)
MK801 antagonism of the prolonged depletion of striatal dopamine by amphetamine in iprindole-treated rats. (1992) (8)
Drugs affecting serotonin neurons. (1990) (8)
Decrease in hypothalamic epinephrine concentration and other neurochemical changes produced by quinpirole, a dopamine agonist, in rats (2005) (8)
Pharmacological profile of LY301317, a potent and selective 5‐HT1A agonist (1997) (8)
Long-lasting depletion of brain serotonin by 4-chloroamphetamine in guinea pigs. (1974) (8)
Metabolism of fenfluramine to norfenfluramine in guinea‐pigs (1988) (8)
Myotonia produced by indoleacetic acid. Studies with related compounds and correlation with drug levels in tissues. (1971) (8)
Amfonelic acid antagonism of dopamine and norepinephrine depletion by alpha-methyl-m-tyrosine in rat brain. (1981) (7)
Persistence of long-lasting serotonin depletion by p-chloroamphetamine in rat brain after 6-hydroxydopamine lesioning of dopamine neurons. (1995) (7)
Quantitation of zinc in nitric acid-digested plasma by atomic absorption spectrophotometry. (1985) (7)
Inhibition of amine uptake by 4-phenyl-bicyclo(2,2,2)octan-1-amine hydrochloride monohydrate (EXP 561) in rats. (1976) (7)
1-(1-Naphthyl)piperazine, a central serotonin agonist. (1986) (7)
Studies on the mechanism of amphetamine-induced lipolysis in the rat. (1972) (7)
Influence of substrate in the inhibition of rat liver and brain monoamine oxidase. (1968) (7)
Inhibition by disulfiram of the accelerated turnover of catecholamines in the adrenal glands of exercised rats (1968) (7)
Effects of some homologues of 4-chloroamphetamine on brain serotonin metabolism. (1974) (7)
An improved method for measuring blood concentrations of phenylpyruvic acid. (1971) (7)
Long‐lasting reduction of brain 5‐hydroxytryptamine concentration by 3‐chloroamphetamine and 4‐chloroamphetamine in iprindole‐treated rats (1974) (7)
Lack of a difference between ketanserin and ritanserin in central vs. peripheral serotonin receptor antagonism. (1989) (7)
Regulation of enzyme activity by glucagon: increased hormonal activity of iodinated glucagon. (1975) (7)
Selective in Vivo Inhibition of Monoamine Oxidase in Rat Tissues by N-[2-(o-Chlorophenoxy)-Ethyl]-Cyclopropylamine (1978) (7)
Elevation of hepatic phenylalanine pyruvate aminotransferase in rat by tetraiodoglucagon is blocked by actinomycin D and cycloheximide. (1973) (7)
Stress. Neurochemical and humoral mechanisms. Volume 1 Edited by G.R. Van Loon, R. Kvetnansky, R. McCarty and J. Axelrod. ISBN 2-88124-339-8. Price: $180.00. Gordon & Breach Science, New York, 1989 (1991) (7)
Comparison of 1-methyl-4-(p-chlorophenyl)-1,2,3,6-tetrahydropyridine, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and p-chloroamphetamine as monoamine depletors. (1985) (7)
Depletion of epinephrine in rat hypothalamus by Ro 4-1284: Influence of pargyline and harmaline (1980) (7)
Role of norfluoxetine in the inhibition of desipramine metabolism and in the inhibition of serotonin uptake after fluoxetine administration to rats. (1991) (6)
The essential role of integrative biomedical sciences in protecting and contributing to the health and well-being of our nation. (1994) (6)
Synergistic elevation of brain 3,4‐dihydroxyphenylacetic acid concentration by methylphenidate and spiperone in control but not reserpine‐pretreated rats (1979) (6)
Effect of haloperidol pre- and post-treatment on the ability of pergolide and bromocriptine to antagonize the gamma-butyrolactone-induced increase in brain dopamine in rats. (1982) (6)
Effect of pergolide on MOPEG sulphate levels in rat brain regions (1983) (6)
Lowering of dopamine metabolites in rat brain by harmaline (1981) (6)
Repeated administration of pergolide to rats attenuates the acute elevation of serum corticosterone by pergolide (1981) (6)
Norepinephrine N-methyltransferase inhibition by benzamidines, phenylacetamidines, benzylguanidines, and phenylethylguanidines. (1975) (6)
The brain's three catecholamines (1983) (6)
Chapter 6. Central Serotonin Receptors: Opportunities for Drug Discovery (1988) (6)
NEUROENDOCRINE AND BEHAVIORAL STUDIES WITH FLUOXETINE, AN INHIBITOR OF SEROTONIN UPTAKE IN BRAIN (1978) (6)
Elevation of epinephrine concentration in rat brain by LY51641, a selective inhibitor of type A monoamine oxidase. (1981) (6)
Elevation of serum prolactin acutely after administration of p-chloroamphetamine in rats. (1980) (6)
Inhibition of rat brain norepinephrine N-methyltransferase by 2,3,4,5-tetrahydro-1H-indeno [1,2-c]-pyridine hydrochloride (LY87130) (1980) (6)
Effect of meta-chlorophenylpiperazine (mCPP), a central serotonin agonist and vascular serotonin receptor antagonist, on blood pressure in SHR. (1987) (6)
Inhibition in vitro of norepinephrine N-methyltransferase by 2-aminotetralins, analogs of phenylethylamines with rigid conformation. (1977) (6)
Inhibition of rat brain norepinephrineN-methyltransferase by 7,8-dichloro-2,3,4,5-tetrahydro-1H-2-benzazepine (1978) (6)
5-Hydroxytryptamine2 receptor antagonist activity of the acid metabolite (1-isopropyl dihydrolysergic acid) of the ergoline ester, sergolexole (LY281067). (1989) (6)
Substrate-selective and tissue-selective inhibition of monoamine oxidase. (1972) (6)
Comparative 5‐HT2‐Receptor Antagonist Activity of Amesergide and its Active Metabolite 4‐Hydroxyamesergide in Rats and Rabbits (1994) (5)
Procaine Hydrochloride as a Monoamine Oxidase Inhibitor: Implications for Geriatric Therapy (1977) (5)
Pharmacologic properties of serotonergic agents and antidepressant drugs. (1987) (5)
LOWERING OF BRAIN EPINEPHRINE BY INHIBITION OF NOREPINEPHRINE N-METHYLTRANSFERASE IN RATS (1979) (5)
Inability of methadone to prevent the depletion of brain 5-hydroxyindoles by p-chloroamphetamine. (1976) (5)
Persistent effects of amphetamine, p-chloroamphetamine, and related compounds on central dopamine and serotonin neurons in rodents. (1985) (5)
Effects of LY104119, a thermogenic weight-reducing compound, on norepinephrine concentrations and turnover in obese and lean mice. (1988) (5)
Tissue levels of metaraminol and its metabolite, alpha-methylnorepinephrine, in control and 6-hydroxydopamine-pretreated guinea pigs. (1981) (5)
Comparative effects of amantadine and amfonelic acid on dopamine metabolism in rat brain (1981) (4)
Flumezapine and zotepine: 5‐hydroxytryptamine antagonism not involved in the lack of synergism of these antipsychotic drugs with amfonelic acid in rats (1985) (4)
Fluoxetine: a clinically effective non-tricyclic antidepressant (1983) (4)
The role of metabolic N‐dealkylation in the action of p‐chlorometham‐phetamine and related drugs on brain 5‐hydroxytryptamine (1977) (4)
Effect of glucagon and dibutyryl cyclic AMP on the tissue distribution of [14C] α‐aminoisobutyric acid in rats (1975) (4)
Serum corticosterone elevation by pergolide in rats: prevention of tolerance development by spiperone (1982) (4)
Formation of alpha-methylnorepinephrine as a metabolite of metaraminol in guinea pigs. (1981) (4)
Effect of lergotrile on3,4-dihydroxyphenylacetic acid (DOPAC) concentration and dopamine turnover in rat brain (2005) (4)
p-Chloroamphetamine formation responsible for long-term depletion of brain serotonin after N-cyclopropyl-p-chloroamphetamine injection in rats. (1987) (4)
Elevation of hepatic phenylalanine: pyruvate aminotransferase by dibutyryl cyclic AMP in rats. (1974) (4)
Hepatic insensitivity to glucagon in ob/ob mice. (1980) (4)
Antagonism by tomoxetine of the depletion of norepinephrine and epinephrine in rat brain by alpha-methyl-m-tyrosine. (1983) (4)
Persistent depletion of striatal dopamine and cortical norepinephrine in mice by 1-methyl-4-phenyl-1,2,3,6-tetrahydro-3-pyridinol (MPTP-3-OL), an analog of MPTP. (1992) (4)
Effect of fluoxetine pretreatment on the neurochemical changes induced by amfonelic acid combined with spiperone in rats (1986) (4)
Inhibition of norepinephrine N-methyltransferase by 1-aminoindans, conformationally rigid analogs of benzylamines. (1978) (4)
MPTP: A Parkinsonism-causing Neurotoxic Substance (1990) (4)
Chapter 3. Progress in Antidepressant Drugs (1991) (4)
The Place of Animal Models and Animal Experimentation in the Study of Food Intake Regulation and Obesity in Humans (1987) (4)
Comparison of fluoxetine and norfluoxetine enantiomers as inhibitors of hexobarbitone metabolism in mice. (1992) (4)
Decreased 5‐hydroxytryptamine turnover in striatum and other brain regions after administration of 5‐methoxy‐3‐(di‐n‐propylamino)‐chroman to rats (1989) (4)
Pergolide elevation of MHPG sulphate concentration in rat hypothalamus blocked by spiperone and mimicked by other dopamine agonists (1985) (3)
Central serotonin antagonist activity of ketanserin. (1984) (3)
Increased conversion of a phenylalanine load to tyrosine in tetraiodoglucagon-treated rats. (1974) (3)
CATECHOLAMINE CONCENTRATION IN THE CEREBELLUM OF PURKINJE CELL DEGENERATION (pcd) MUTANT MICE (1980) (3)
Phenethanolamine N-methyl transferase and adrenocortical activity in the neonatal rat. (1969) (3)
Effects of prolintane on 3,4-dihydroxyphenylacetic acid concentration in rat brain after spiperone treatment (1979) (3)
In vivo effects of LR5182, cis-3-(3,4-dichlorophenyl)-2-N,N-dimethylaminomethyl-bicyclo-[2,2,2]-octane hydrochloride, an inhibitor of uptake into dopamine and norepinephrine neurons (1979) (3)
Biphasic effects of m-chlorophenyl-piperazine on 3,4-dihydroxyphenylacetic acid concentration in rat brain. (1977) (3)
Increase in serum corticosterone concentration and decrease in hypothalamic epinephrine concentration by N-propylnorapomorphine in rats. (1984) (3)
Molindone: higher doses needed to block pergolide-induced elevation of serum corticosterone than to elevate dopamine metabolites in brain. (1983) (3)
Functional consequences of inhibiting serotonin uptake with fluoxetine in rats. (1982) (3)
Decreased hypothalamic epinephrine concentration by quipazine and other serotonin agonists in rats. (1995) (3)
Properties of norepinephrine N-methyltransferase from rat, cat and chicken brain. (1979) (3)
Effects of amfonelic acid, alpha-methyltyrosine, Ro 4-1284 and haloperidol pretreatment on the depletion of striatal dopamine by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice. (1985) (3)
Neurochemical effects of CM 57227 and CM 57373, two anorectic agents, on brain serotonin neurons in rats (1990) (3)
Species difference in the lowering of brain 5‐hydroxytryptamine by m‐chloroamphetamine (1972) (3)
Depletion of brain serotonin by chronic administration of p-chloramphetamine orally to rats and dogs. (1979) (3)
Comparative brain levels of phenylpropanolamine and amphetamine in rats. (1992) (2)
Brain Monoaminergic Neurons: Distribution and Function in Relation to Regulation of Autonomic, Neuroendocrine and Immune Systems (1986) (2)
Duration of the effects of α‐ethyl‐4‐methyl‐m‐tyramine, (H75/12) on brain 5‐hydroxyindole concentrations in rats (1976) (2)
5,6-Dihydroxytryptamine is a substrate for catechol O-methyltransferase. (1974) (2)
Effect of 4-(4-methoxy-1,2,5-thiadiazol-3-yl)-1-methyl-1,2,3,6-tetrahydropyridine, an analog of MPTP, on mouse heart norepinephrine and brain catecholamines (1993) (2)
Role of type A and Type B MAO in the metabolism of epinephrine in rat brain (1981) (2)
Modification by harmaline of the effects of N‐cyclopropyl‐p‐chloroamphetamine on 5‐hydroxyindole concentration in rat brain (1979) (2)
Fluoxetine at anorectic doses does not have properties of a dopamine uptake inhibitor (2005) (2)
Antagonism by L-dopa of the elevation of hypothalamic epinephrine by monoamine oxidase inhibition in rats. (1981) (2)
Effect of mazindol on brain dopamine turnover in spiperone-treated rats (2005) (2)
Pharmacology of para-chloroamphetamine and analogs. (1976) (2)
Comparison of o-octopamine and related phenylethanolamines as substrates for norepinephrine N-methyltransferase. (1981) (2)
Ihibition of rat brain norepinephrine N-methyltransferase in vitro and in vivo by chloro-substituted 1-aminoindans. (1980) (2)
AL-1576, an aldose reductase inhibitor (ARI), did not prevent the decrease of norepinephrine turnover in diabetic rats. (1988) (2)
[76] Norepinephrine N-methyltransferase from rabbit adrenal glands (1987) (2)
Studies on 4-(p-bromophenyl)-bicyclo (2,2,2) octan-1-amine as an inhibitor of uptake into serotonin neurones (1978) (2)
Antagonism by (−)‐methadone of the depletion of 5‐hydroxytryptamine in rat brain by p‐chloroamphetamine (1981) (2)
Antagonism of Serotonin Agonist-Elicited Increases in Serum Corticosterone Concentration in Rats (1991) (2)
6-Substituted 1,3,4,5-Tetrahydrobenz(cd)indol-4-amines: Potent Serotonin Agonists. (1989) (2)
Substituted phenylpiperazines as serotonin agonists: structural determinants of potency and interaction with receptor subtypes. (1986) (2)
Nisoxetine prevents the 6-hydroxydopamine induced decrease in post-decapitation convulsions. (1977) (2)
Studies on maxindol as an amine uptake inhibitor. (1978) (2)
5'-THIODENOSINE DERIVATIVES AS POTENT AND SELECTIVE INHIBITORS OF HISTAMINE N-METHYL-TRANSFERASE (1989) (2)
Influence of PKa on the methylation of arylalkylamines by rabbit lung N-methyltransferase. (1975) (2)
SPECIFICITY IN THE INHIBITION OF MONOAMINE UPTAKE (1984) (1)
Inhibition of brain epinephrine synthesis by 3,4-dichlorophenylethanolamine, a competitive substrate for norepinephrine N-methyltransferase. (1983) (1)
Effect of phenobarbital on the metabolism and serotonin-depleting action of 4-chloro-beta, beta-difluoroamphetamine in rats. (1974) (1)
Elevation of serum corticosterone in rats by bremazocine, a kappa-opioid agonist. (1984) (1)
Fenfluramine and Parkinson's disease. (1977) (1)
Inability of monoamine oxidase inhibitors to prevent to persistent depletion of striatal dopamine by amphetamine in rats (1984) (1)
Norepinephrine N-methyltransferase from rabbit adrenal glands. (1987) (1)
Effect of some lipid‐soluble derivatives of amphetamine on amphetamine levels in rat brain (1973) (1)
alpha 2 Adrenoreceptor affinity of some inhibitors of norepinephrine N-methyltransferase. (1981) (1)
Effect of glucagon and dibutyryl cyclic AMP on the tissue distribution of [14-C] alpha-aminoisobutyric acid in rats. (1975) (1)
Properties of norepinephrine N-methyltransferase from pigeon brain (1979) (1)
Antidiarrhoeal effects of quipazine and 1‐(m‐trifluoromethyl‐phenyl)piperazine in mice (1981) (1)
Methylation of norepinephrine and alpha-methylnorepinephrine in brain. (1982) (1)
Steric influence on inhibition of monoamine oxidase forms by 2,3-dichloro-alpha-methylbenzylamine. (1978) (1)
Depletion of cardiac norepinephrine but not brain catecholamines by MPTP-N-oxide in mice. (1990) (1)
INHIBITION OF MONOAMINE OXIDASE ACTION ON KYNURAMINE BY SUBSTRATE AMINES AND STEREOISOMERIC ALPHA-METHYL AMINES. (1965) (1)
Suppression of milk drinking by the combination of fluoxetine and L-5-hydroxytryptophan in rats. (1981) (1)
Recommendations for future research on amphetamines and related designer drugs. (1989) (1)
Drug Discovery at the Enzyme Level (1987) (1)
CNS stimulant properties and physiologic disposition of Β,Β-difluorophenylethylamine in mice (2004) (1)
Depletion of heart norepinephrine in mice by some analogs of MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine). (1987) (1)
Effects of N-cyclopropyl-4-chloroamphetamine on brain serotonin metabolism in rats. (1973) (1)
Depletion of epinephrine in rat hypothalamus by a dopamine agonist, pergolide (1982) (1)
Further evidence for serotonin involvement in thermoregulation following morphine administration from studies with an inhibitor of serotonin uptake. (1974) (1)
Persistent depletion of striatal dopamine in mice by m-hydroxy-MPTP. (1986) (1)
Further characterization of tolerance to the corticosterone-elevating effect of pergolide in rats (1988) (1)
Dopamine and 5-HT receptor sensitivity does not correlate with neostriatal dopamine or 5-HT content. (1996) (1)
Dissociation of the lipid mobilizing and hyperthermic effects of amphetamine by beta-fluoro substitution. (1972) (1)
Effect of uptake inhibitors on the depletion of brain norepinephrine and serotonin after alpha-methyl-m-tyrosine administration to rats. (1978) (1)
Effect of 2-(p-chlorophenyl)cyclopropylamine on 5-hydroxyindole concentration and monoamine oxidase activity in rat brain. (1980) (1)
Analogue of fluoxetine. (1989) (0)
GENERAL DISCUSSION (1978) (0)
Inhibition of monoamine oxidase by 3-amino-2-oxazolidinone and 2-hydroxy-ethylhydrazine (1971) (0)
Effect of p-chloroamphetamine on serotonin content of the rat pineal gland. (1977) (0)
Position of a chloro substituent on phenylethanolamine as a determinant of methylation by rabbit adrenal norepinephrine N-methyltransferase. (1977) (0)
Daily cyclic variation in liver tyrosine alpha-ketoglutarate trans- aminase (tkt) in rats and mice. Abstr. (1968) (0)
Fluoxetine analogs, process for their preparation and to pharmaceutical compositions containing such (1989) (0)
An ImprovedMethodfor MeasuringBlood Concentrationsof Phenylpyruvic Acid (2004) (0)
Ionophore (A23187)-induced efflux of [3H]norepinephrine and endogenous norepinephrine in the rat vas deferens. (1981) (0)
Elevation of hepatic tyrosine 2-oxoglutarate aminotransferase in rats by 4-pentynoic acid, a hypoglycemic agent (1973) (0)
Serotonergic drugs increase mhpg sulfate in rat hypothalamus (1991) (0)
Effect of cholinomimetic drugs in combination with amfonelic acid or spiperone on the concentration of 3,4-dihydroxyphenylacetic acid in rat brain. (1978) (0)
Dialysis rate as a rapid measurement of tryptophan binding to albumin. (1974) (0)
New inhibitors of dopamine beta-hydroxylase. (1976) (0)
Effect of cis and trans isomers of 1-amino-2-(p-chlorophenyl)cyclohexane, conformationally restricted analogs of p-chloroamphetamine, on 5-hydroxyindoles in rat brain. (1982) (0)
Methylation of non-phenyl ethanolamines by norepinephrine N-methyltransferase. (1977) (0)
Endocrine and neurochemical effects of (+)-PHNO, a dopamine D2 agonist (2005) (0)
The atypical antipsychotic olanzapine blocks muscarinic, serotonergic and dopamine receptors (1995) (0)
AnImproved MethodforMeasuring Blood Concentrations ofPhenylpyruvic Acid (1971) (0)
Comparison of L-5-hydroxytryptophan and L-5-hydroxytryptophan inosinate as agents for increasing brain serotonin formation in rats. (1992) (0)
Norepinephrine N-methyltransferase in brain (1982) (0)
Comparative effects of p-chloroamphetamine and 1-(p-chlorophenyl)piperazine on 5-hydroxyindole concentration in rat brain. (1980) (0)
Preliminary report on use of sulfamethazine and penicillin in bovine mastitis. (1949) (0)
5'-thioadenosine derivatives as potent and selective inhibitors of histamine N-methyltransferase. (1989) (0)
Sensitization to dopamine (DA) and 5-hydroxy-tryptamine (5-HT) agonists is not correlated with alterations in DA and 5-HT contents of neostriatum after neonatal intrastriatal 6-hydroxydopamine injections in rats (1995) (0)
Comparative effects of 1-ethyl- and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridines on catecholamine concentrations in mouse brain and heart. (1988) (0)
SAT-5-4 Olanzapine: An exciting atypical antipsychotic — the preclinical profile (1995) (0)
PURIFICATION AND PROPERTIES OF ANTIPLASMIN FROM BOVINE AND HUMAN BLOOD SERUMS (1961) (0)
Comparison of some conformationally rigid benzylamine analogs as substrates for rabbit lung N-methyltransferase. (1980) (0)
Comparison of the rates of N-methylation of norepinephrine and alpha-methylnorepinephrine by brain stem homogenates from three species. (1983) (0)
Evidence for inhibition of monoamine oxidase in vivo in rat brain by 7,8-dichloro-1,2,3,4-tetrahydroisoquinoline. (1983) (0)
Effect of cycloserine stereoisomers and theophylline on the release of tritium from 2-tritio-L-alanine. (1976) (0)
Potent in vivo but not in vitro inhibition of monoamine oxidase by 3-chloro-α-phenylpyrazinemethanol (1992) (0)
Metabolism of amphetamine and beta,beta-difluoroamphetamine in phenobarbital-treated rats. (1973) (0)
FLUOXENTINE, A SELECTIVE INHIBITOR OF SEROTONIN UPTAKE IN ANIMAL STUDIES (1984) (0)
Effect of p-chloramphetamine on the inactivation of monoamine oxidase in rat brain by 3-amino-2-oxazolidinone, 2-hydroxyethylhydrazine and pheylisopropylhydrazine. (1978) (0)
NOREPINEPHRINE N‐METHYLTRANSFERASE INHIBITION BY BENZAMIDINES, PHENYLACETAMIDINES, BENZYLGUANIDINES, AND PHENYLETHYLGUANIDINES (1975) (0)
Of dihydrolysergic acid esters, process for their preparation, intermediates for use thereby, and compositions containing the active compounds (1986) (0)
A process for the preparation of 9,10- dihydrolysergic acid esters. (1986) (0)
Effect of beta-fluorophenethylamine analogs on monoamine oxidase substrate preference. (1978) (0)
Letter: Effect of some lipid-soluble derivatives of amphetamine on amphetamine levels in rat brain. (1973) (0)
Inability of imipramine to protect against type A or type B monoamine oxidase inhibition by pargyline. (1979) (0)
Effects of pre- and post-treatment with EXP 561 on the amine-depleting effects of p-chloroamphetamine and 6-hydroxydopamine in rats. (1978) (0)
Circulation Research provides a medium for bringing together basic research on the cardiovascular sys- tem from various disciplines including biology, biochemistry, biophysics, morphology, pathology, physiology, and pharmacology. The Journal also will accept for publication manuscripts on clinical r (1977) (0)
Phenylpropanolamine and amphetamine: comparative effects on striatal dopamine neurons in iprindole-treated rats (1983) (0)
Role of Serotonin in Regulation of the Pituitary-Adrenocortical Axis in Rats (1990) (0)
Note on the Constitution of Diparabromben-Zylcyanamide (0)
In Vivo Cardiovascular Responses to Isoproterenol, Dopamine, and Tyramine Following Prolonged Infusion of Isoproterenol (1986) (0)

This paper list is powered by the following services:

Ray Ward Fuller's Academic­Influence.com Rankings

Ray Ward Fuller's Degrees

Similar Degrees You Can Earn

Why Is Ray Ward Fuller Influential?

Ray Ward Fuller's Published Works

Published Works

Ray Ward Fuller's AcademicInfluence.com Rankings